Augmenting Obstructive Sleep Apnea Chronic Care Management With Consumer Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnea
- Sponsor
- VA Greater Los Angeles Healthcare System
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- PAP adherence (minutes)
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial in adults with obstructive sleep apnea prescribed positive airway pressure therapy is to test the effects of a new patient-facing consumer wearable-based program (that involves provision of a consumer wearable that measures oxygen levels during sleep plus customized weekly reports to participants). The main question is to learn whether participants' use of positive airway pressure therapy will differ between the participants who receive the new program immediately versus delayed. Participants assigned to the delayed program will receive usual care while waiting for the program to begin.
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening to determine eligibility for study entry. Patients who meet the eligibility requirements will be randomized to immediate versus waitlist control in a 1:1 ratio. Our project is at the forefront of consumer wearable research, leveraging the recent capabilities of consumer wearables to provide pulse oximetry data during sleep, to uncover new ways to promote PAP usage among patients with obstructive sleep apnea.
Investigators
Constance Fung
Principal Investigator
VA Greater Los Angeles Healthcare System
Eligibility Criteria
Inclusion Criteria
- •Prescribed PAP therapy from the sleep center for \> 1 week
- •Have an active profile in our Center's ResMed AirView or Respironics Care Orchestrator accounts for \> 1 week
- •Non-adherent with PAP therapy
- •Willing to continue using current PAP device for 28 days continuously
- •Have an electronic device compatible with the wearable app
Exclusion Criteria
- •Diagnosis of heart failure, chronic lung disease, dementia, active substance use disorder
- •Use home oxygen
- •Unstable medical or psychiatric illness
- •Planned non-use of PAP therapy (e.g., waiting for replacement of recalled PAP device)
- •Planned surgery or hospitalization during study period
- •Planned extensive travel during study period
- •History of repeated non-attendance at clinic visits
Outcomes
Primary Outcomes
PAP adherence (minutes)
Time Frame: 5 weeks
Change in mean minutes of PAP use per night between baseline (T1) and post-treatment (T3).
Secondary Outcomes
- PAP adherence (percent of days used >= 4 hours)(5 weeks)